share_log

What's Next: BioXcel Therapeutics's Earnings Preview

What's Next: BioXcel Therapeutics's Earnings Preview

接下來是bioxcel therapeutics的收益預覽
Benzinga ·  11/13 23:02

BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.

bioxcel therapeutics (納斯達克:BTAI) 將於2024年11月14日(星期四)發佈最新的季度業績。以下是投資者在公告前需要了解的信息。

Analysts estimate that BioXcel Therapeutics will report an earnings per share (EPS) of $-0.52.

分析師估計bioxcel therapeutics的每股收益(EPS)爲-$0.52。

The market awaits BioXcel Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

市場期待bioxcel therapeutics的公告,希望能夠超出預期並提供積極的下一個季度指引。

It's important for new investors to understand that guidance can be a significant driver of stock prices.

新投資者需要明白,指引對股價有重要影響。

Overview of Past Earnings

過去收益的概述

During the last quarter, the company reported an EPS beat by $0.50, leading to a 5.06% drop in the share price on the subsequent day.

在上個季度,該公司報告的每股收益超出預期$0.50,導致次日股價下跌5.06%。

Here's a look at BioXcel Therapeutics's past performance and the resulting price change:

以下是bioxcel therapeutics過去表現及相應的價格變動情況:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.71 -0.70 -0.91 -1.31
EPS Actual -0.21 -0.87 -0.76 -1.58
Price Change % -5.0% -9.0% 4.0% 4.0%
季度 2024年第二季度 2024年第一季度 Q4 2023 Q3 2023
每股收益預估值 -0.71 -0.70 -0.91 -1.31
每股收益實際值 -0.21 -0.87 -0.76 -1.58
價格變更% -5.0% -9.0% 4.0% 4.0%
bigjpg

Stock Performance

股票表現

Shares of BioXcel Therapeutics were trading at $0.665 as of November 12. Over the last 52-week period, shares are down 84.48%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

截至11月12日,bioxcel therapeutics的股價爲0.665美元。在過去的52周裏,股價下跌了84.48%。考慮到這些收益通常是負面的,長期股東在這次業績發佈前可能會感到不滿。

To track all earnings releases for BioXcel Therapeutics visit their earnings calendar on our site.

要跟蹤bioxcel therapeutics的所有業績發佈,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文是由Benzinga的自動內容引擎生成,並由編輯審核。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論